ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

LSL LSL Pharma Group Inc

0.385
0.00 (0.00%)
29 Jan 2025 - Closed
Delayed by 15 minutes

LSL Pharma Financial Summary

The current LSL market cap is 31.74M. The company's latest EPS is CAD -0.1028 and P/E is -3.70.

Year End 31 December 2023 20222023
CAD ($)CAD ($)
Total Revenue 010.03M
Operating Income -3k-6.67M
Net Income -74k-8.47M
Year End 31 December 2023 20222023
CAD ($)CAD ($)
Total Assets 25k30.9M
Total Liabilities 285k22.25M
Total Equity -260k8.66M

Cash Flow

Year End 31 December 2023 20222023
CAD ($)CAD ($)
Operating -3k-7.07M
Investing N/A -1.02M
Financing 3k8.1M
Market Cap 31.74M
Price to Earnings Ratio -3.70
Price to Sales Ratio 3.13
Price to Cash Ratio 3.8k
Price to Book Ratio 3.62
Dividend Yield -

Share Statistics

Shares Outstanding 82.44M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.01 (1.3%)

Company Info

Company Name LSL Pharma Group Inc
Address 540, rue d’avaugour, boucherville
quebec city, quebec J4B 0G6
Website https://www.groupelslpharma.com
Industry blank checks (6770)

Your Recent History

Delayed Upgrade Clock